<DOC>
	<DOCNO>NCT00553865</DOCNO>
	<brief_summary>The purpose study determine optimal dosage clinical trial evaluate antihypertensive efficacy safety OJP-2028 tablet patient uncomplicated essential hypertension .</brief_summary>
	<brief_title>Clinical Trial Evaluate Efficacy Safety Antihypertensive Tablets</brief_title>
	<detailed_description>Evaluating antihypertensive efficacy safety OJP-2028 tablet patient uncomplicated essential hypertension .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>1 . Adult men woman ( Age 1875 year ) 2 . Uncomplicated essential hypertension : Clinic sit SiDBP 90 109 mmHg 2 week placebo runin period 1 . Secondary hypertension 2 . History and/or sign cardiovascular complication ( eg ; myocardial infarction , unstable angina ) 3 . Pregnancy lactation 4 . Contraindications antihypertensive drug use treatment period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>